Lichen sclerosus.


Authors: M. Pešek;  J. Bouda;  Z. Rokyta
Authors‘ workplace: Gynekologicko-porodnická klinika LF UK a FN Plzeň
Published in: Prakt Gyn 2009; 13(3): 153-157

Overview

Lichen sclerosus (LS) belongs to frequent non‑neoplastic epithelial disorders of the vulva. Patients suffer with intensive pruritus or dyspareunia. Ethiology of LS is unclear, there is a risk of progressive scarring of external genitalia and patients with LS have increased risk of developing squamous cell carcinoma of the vulva (3–5%). A potent local corticosteroid is a treatment of choice. Frequent reccurences require repeated therapy. A close follow‑up in a 6-months intervals and biopsy of all atypical lesions is required. Surgery is rarely indicated in the management of LS.

Key words:
lichen sclerosus – non‑neoplastic epithelial disorders – clobetazol propionate – tacrolimus


Sources

1. Goldstein AT, Marinoff SC, Christopher K et al. Prevalence of vulvar lichen sclerosus in a general gynecology practice. J Reprod Med 2005; 50(7): 477–480.

2. Meffert JJ, Davis BM, Grimwood RE. Lichen sclerosus. J Am Acad Dermatos 1995; 32(3): 393–416.

3. Powell JJ, Wojnarowska F. Lichen sclerosus. Lancet 1999; 353(9166): 1777–1783.

4. Friedrich EG Jr, Kalra PS. Serum levels of sex hormones in vulvar lichen sclerosus and the effect of topical testosterone. N Engl J Med 1984; 310(8): 488–491.

5. Sideri M, Origoni M, Spinaci L et al. Topical testosterone in the treatment of vulvar lichen sclerosus. Int J Gynaecol Obstet 1994; 46(1): 53–56.

6. Preti M, Micheletti L, Barbero M et al. Psychological distress in women with non‑neoplastic disorders of the vulva. J Reprod Med 1994; 39(12): 961–963.

7. Cooper SM, Gao XH, Powell JJ et al. Does treatment of vulvar lichen sclerosus influence its prognosis? Arch Dermatol 2004; 140(6): 702–706.

8. Leibowitch M, Neill S, Pelisse M et al. The epithelial changes associated with squamous cell carcinoma of the vulva; a review of the clinical, histological and viral findings in 78 women. Br J Obstet Gynaecol 1990; 97(12): 1135–1139.

9. Tan SH, Derrick E, McKee PH et al. Altered p53 expression and epidermal cell proliferation is seen in vulval lichen sclerosus. J Cutan Pathol 1994; 21(4): 319–323.

10. Val I, Almeida G. An overview of lichen sclerosus. Clin Obstet Gynecol 2005; 48(4): 808–817.

11. Ansink AC, Krul MR, De Weger RA et al. Human papillomavirus, lichen sclerosus and squamous cell carcinoma of the vulva: detection and prognostic significance. Gynaecol Oncol 1994; 52(2): 180–184.

12. Raspollini MR, Asirelli G, Moncini D et al. A comparative analysis of lichen sclerosus of the vulva and lichen sclerosus that evolves to vulvar squamous cell carcinoma. Am J Obstet Gynecol 2007; 197(6): 592–595.

13. Farrell AM, Dean D, Wojnarowska F. Vulval lichen sclerosus: a study of its inflammatory infiltrate. Br J Dermatol 1997; 136: 462. Abstract.

14. Farrell AM, Millard P, Wojnarowska F. An infective aetiology for lichen sclerosus: myth or reality? Br J Dermatol 1997; 137: 25. Abstract.

15. Marren P, Charnock M, Wojnarowska F et al. The basement membrane zone in lichen sclerosus: an immunohistochemical study. Br J Dermatol 1997; 136(4): 508–514.

16. Marren P, Yell J, Charnock FM et al. The association between lichen sclerosus and antigens of the HLA system. Br J Dermatol 1995; 132(2): 197–203.

17. Powell J, Wojnarowska F, Marren P. Lichen sclerosus autoimmunity and immunogenetics-DQ7 is most associated with onset in females in childhood. Br J Dermatol 1998; 139: 47.

18. Schempp C, Bocklage H, Lange R et al. Further evidence for Borrelia burgdorferi infection in morphea and lichen sclerosus et atrophicus confirmed by DNA amplification. J Invest Dermatol 1993; 100(5): 717–720.

19. Shelley WB, Shelley ED, Amurao CV. Treatment of lichen sclerosus with antibiotics. Int J Dermatol 2006; 45(9): 1104–1106.

20. Drut RM, Gómez MA, Drut R et al. Human papillomavirus is present in some cases of childhood penile lichen sclerosus: an in situ hybridisation and SP‑PCR study. Pediatr Dermatol 1998; 15(2): 85–90.

21. Bracco GL, Carli P, Sonni L et al. Clinical and histologic effect of topical treatments of vulval lichen sclerosus. A critical evaluation. J Reprod Med 1993; 38(1): 37–40.

22. Smith YR, Quint EH. Clobetasol propionate in the treatment of premenarchal vulvar lichen sclerosus. Obstet Gynecol 2001; 98(4): 588–591.

23. Assmann T, Becker-Wegerich P, Grewe M et al. Tacrolimus ointment for the treatment of vulvar lichen sclerosus. J Am Acad Dermatol 2003; 48(6): 935–937.

24. Kunstfeltd R, Kirnbauer R, Stingl G et al. Successful treatment of vulvar lichen sclerosus with topical tacrolimus. Arch Dermatol 2003; 139(7): 850–852.

25. Böhm M, Frieling U, Luger TA et al. Successful treatment of anogenital lichen sclerosus with topical tacrolimus. Arch Dermatol 2003; 139(7): 922–924.

26. van de Nieuwenhof HP, van der Avoort IA, de Hullu JA. Review of squamous premalignant vulvar lesions. Crit Rev Oncol Hematol 2008; 68(2): 131–156.

27. Bousema MT, Romppanen U, Geiger JM et al. Acitretin in the treatment of severe lichen sclerosus et atrophicus of the vulva; a double blind, placebo-controlled study. J Am Acad Dermatol 1994; 30(2 Pt 1): 225–231.

Labels
Paediatric gynaecology Gynaecology and obstetrics Reproduction medicine
Login
Forgotten password

Don‘t have an account?  Create new account

Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account